Thoracic Surgery
Conditions
Interventions
A multicenter, double-blind, randomized controlled clinical trial will be conducted from March 2019 to December 2023 at the Santa Maria University Hospital - HUSM, which is the study's coordinating ce
for masking, the patient will not be informed about the group to which he or she belongs. Cardiopulmonary rehabilitation protocol phase I associated with IS (n=46): The IS procedure will not be masked
E02.190.525.186
Sponsors
Universidade Federal de Santa Maria
Instituto de Cardiologia do Rio Grande do Sul - Fundação Universitária de Cardiologia
Eligibility
Age
40 Years to No maximum
Inclusion criteria
Inclusion criteria: Age over 40 years; preoperative valve replacement; preoperative myocardial revascularization; both sexes
Exclusion criteria
Exclusion criteria: Previous diagnosis of infectious disease; severe uncorrected valvulopathy; severe lesion of the left main coronary artery; congestive heart failure; unstable angina; peripheral neuropathy; nephropathy; severe musculoskeletal disease; morbid obesity; cancer patients undergoing chemotherapy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Identification of length of hospital stay, through analysis of medical records;Identification of the time of invasive mechanical ventilation, through analysis of medical records;Identification of postoperative complications through analysis of medical records;Identify mortality rate through medical record analysis;Identification of demographic characteristics through analysis of medical records;Identification of clinical characteristics through analysis of medical records and interviews with the subject;Identification of risk factors in the pre-surgical period carried out through analysis of medical records and interview with the subject | — |
Secondary
| Measure | Time frame |
|---|---|
| Assessment of respiratory muscle strength, through manovacuometry, where the reference values ??will be given by means of an equation to calculate the maximum inspiratory pressure (MIP) and maximum expiratory pressure (MEP) according to the sex and age of each individual. For male subjects the equation will be used: MIP: y = -0.80 × age + 155.3 MEP: y = -0.81 × age + 165.3 and for women: MIP: y = -0.49 × age + 110.4 MEP: y = -0.61 × age + 115.6;Assessment of vital capacity measured during a spirometry test, which assesses lung function. For each individual, there is a range of normality relative to the values ??recorded by the test, according to age, height, weight and ethnicity. With the result, we can observe lung function and monitor obstructions in the airways;Peak expiratory flow is assessed during spirometry, which indicates a patient's maximum expiration speed. With the result, we can assess the subject's ability to cough, as well as observe lung function and monitor obstructions in the airways. Normal peak expiratory flow values ??vary according to age, sex, race, height and smoking status;Assessment of lower limb muscular endurance through the five-times sit-to-stand test. When observed, longer times to sit-to-stand are related to a higher risk of recurrent falls, slow walking pace and deficits in other activities of daily living. In addition, reduced exercise capacity and muscle strength in the quadriceps are observed in patients with chronic obstructive pulmonary disease.;Assessment of functional capacity through the 6-minute walk test, which is capable of assessing an individual's response to exercise and provides a global analysis of the respiratory, cardiac and metabolic systems. The ideal values ??for each individual depend on variables such as sex, age, height and weight, and an equation is used to estimate the predicted distance value for each subject. For men, the following formula is used: 6MWT distance (m): (7.57 x height cm) – (5.02 x age) – (1. | — |
Countries
Brazil
Contacts
Public ContactCarine Callegaro
Universidade Federal de Santa Maria
Outcome results
None listed